As of October 31, 2019, the largest concentration of Candida auris cases — 427 of 911 confirmed cases — is in New York4, according to an article on the Infection Control Today website.
“Approximately 3 years into the New York outbreak, these pan-resistant isolates still appear to be rare, but their emergence is concerning,” investigators have said.
C. auris cases in New York are primarily concentrated among hospital patients and nursing home residents in New York City.
The investigators recommended that patients on antifungal treatment for C. auris should be monitored closely for clinical improvement, and follow-up cultures should be obtained.
How Efficiency Checklists Help Hospitals Save Energy, Water and Money
Intermountain Healthcare Receives $50M Gift for Standalone Children's Hospital
Arrowhead Regional Medical Center Reports Data Breach via Third Party
Safety Synergy: Infection Prevention That Protects Patients and Workers
Prefabricated Wall Panels Speed UCF Lake Nona Medical Center Construction